Beleaguered Biogen has been handed some encouraging news from the FDA, after the regulator agreed to complete its review of amyotrophic lateral sclerosis (ALS) therapy tofersen within six months ...

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...

A high-level overview of Eli Lilly and Company (LLY) stock. View (LLY) real-time stock price, chart, news, analysis, analyst reviews and more.

Find out if Eli Lilly and Co (LLY:XNYS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the company's ...

Read about Eli Lilly and Co (LLY:XNYS) stock and today's latest news and financial updates.

View the most recent data and latest information on option chains for Eli Lilly and Company Common Stock (LLY) at Nasdaq.com.